Lupus clinical trials in New York
26 studies for Lupus are looking for participants at sites in New York.
Cities in New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- New York Medical College, Hawthorne
- NorthWell, New Hyde Park
RecruitingPhase 2
Ages 16 to 70 · All sexes · Updated Sep 17, 2026 · NCT07328581Transcutaneous Vagus Nerve Stimulation in SLE
- Feinstein Institutes for Medical Research, Manhasset
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06987565HEALTH Home Urinalysis Testing
- NYU Langone Health, New York
Recruiting
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07823478A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, New Hyde Park
- Research Site, New York
- Research Site, The Bronx
- and 1 more
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 10, 2026 · NCT05835310A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, New York
- Research Site, Syracuse
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Sep 10, 2026 · NCT06897930A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
- New York University School Of Medicine, New York
RecruitingPhase 4
Ages 18 to 75 · All sexes · Updated Sep 9, 2026 · NCT06875960A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50010, Brooklyn
- Sl0044 50264, Manhasset
- Sl0044 50077, New York
- and 1 more
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Sep 4, 2026 · NCT06617325A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Kings County Hospital Center - Brooklyn, Brooklyn
RecruitingObservational study
Ages 16 and older · All sexes · Updated Sep 3, 2026 · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Rochester, Rochester
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Aug 26, 2026 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Icahn School of Medicine at Mount Sinai, New York
- State University of New York Upstate Medical Center (SUNY), Syracuse
RecruitingPhase 2
Ages 12 to 65 · All sexes · Updated Aug 24, 2026 · NCT07053800A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Northwell Health, Great Neck
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 21, 2026 · NCT06570798Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- VA NY Harbor Healthcare System, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- and 2 more
RecruitingPhase 3
Ages 55 and older · All sexes · Updated Aug 20, 2026 · NCT05799378Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Stony Brook Internists PC, East Setauket
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 30, 2026 · NCT05268289A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Fairport
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Jul 27, 2026 · NCT07260877Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07138898Trial of Belimumab in Early Lupus
- Feinstein Institute, Manhasset
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT03543839A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Jun 5, 2026 · NCT06613360A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- US08-0, Syracuse
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Jun 2, 2026 · NCT06625671A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
- NYU Langone Medical Center/Hospital for Joint Diseases, New York
- Hospital for Special Surgery, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 45 · Women · Updated Apr 28, 2026 · NCT00198068Alnuctamab for Refractory SLE (LATTE Study)
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 1
Ages 18 to 60 · All sexes · Updated Apr 21, 2026 · NCT07219563Lupus Landmark Study: A Prospective Registry and Biorepository
- The Feinstein Institutes for Medical Research, Manhasset
- Columbia University Medical Center, New York
- Northwell Health, New York
- and 1 more
RecruitingObservational study
Ages 18 to 110 · All sexes · Updated Apr 15, 2026 · NCT05934149Safety of the Herpes Zoster Subunit Vaccine in Lupus
- NYU Langone Health, New York
RecruitingPhase 4
Ages 18 to 90 · All sexes · Updated Dec 26, 2025 · NCT05559671Safety and Efficacy of ONT01 in Lupus
- Hospital for Special Surgery, New York
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Nov 20, 2025 · NCT07107659From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.